INSOMNIA is the #9 most commonly reported adverse reaction for BUPROPION HYDROCHLORIDE, manufactured by Bausch Health US LLC. There are 4,449 FDA adverse event reports linking BUPROPION HYDROCHLORIDE to INSOMNIA. This represents approximately 2.1% of all 208,986 adverse event reports for this drug.
Patients taking BUPROPION HYDROCHLORIDE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA4,449 of 208,986 reports
INSOMNIA is a less commonly reported adverse event for BUPROPION HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of BUPROPION HYDROCHLORIDE
In addition to insomnia, the following adverse reactions have been reported for BUPROPION HYDROCHLORIDE:
INSOMNIA has been reported as an adverse event in 4,449 FDA reports for BUPROPION HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with BUPROPION HYDROCHLORIDE?
INSOMNIA accounts for approximately 2.1% of all adverse event reports for BUPROPION HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking BUPROPION HYDROCHLORIDE?
If you experience insomnia while taking BUPROPION HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.